ATLANTA, July 11, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY ), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that the Company has been invited to present at the Women's Health Panel Discussion, presented by Maxim Group LLC and hosted by M-Vest, on Wednesday, July 13th, 2022 at 11:00 a.m. ET.
During this on-demand virtual event, Kathy Lee-Sepsick, Founder, President and Chief Executive Officer, will participate in the panel detailed below:
Panel title: "A tipping point in women's health - does the SCOTUS outcome change the paradigm in contraception?"
Panel Description: "This is the most critical ...
Full story available on Benzinga.com